one (1) year Equipment/System Maintenance Service Agreement contract plus four (4), one year option periods agreements for two (2) existing NextSeq 500 sequencing machines

The U.S. Food & Drug Administration intends to issue a sole-source purchase order to Illumina, Inc. to purchase a one (1) year Equipment/System Maintenance Service Agreement contract plus four (4), one year option periods agreements for two (2) existing NextSeq® 500 sequencing machines (System and Serial Number: SV-450-1003 S/N: NS50029 and SV-450-1003 S/N: NS500287) at the FDA's facility located in College Park, MD 20740. Both machines need to be maintained in a manner that does not void the warranty provided by manufacturing company Illumina. Award will be made in accordance with Federal Acquisition Regulation (FAR) Part 6.302-1, only one responsible source and no other supplies or services will satisfy agency requirements using Simplified Acquisition Procedures per FAR Part 13. Illumina, Inc. is the sole-supplier and only authorized party to offer extended warranty services for such equipment. The resulting purchase order will be a Firm Fixed Price Purchase order. This notice of intent is not a request for competitive quotes. However, all responsible sources may submit a capability statement within five (5) days after the publication of this synopsis which shall be considered by the agency. Responses received after 5 days or without the required information may not be considered. A determination by the Government not to compete as a result of information received is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. For information concerning this acquisition, contact Sarah Hussain, Contract Specialist at sarah.hussain@fda.hhs.gov or call 240-402-3796.